Bhupender Kumar

665 total citations
28 papers, 490 citations indexed

About

Bhupender Kumar is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Bhupender Kumar has authored 28 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Cancer Research and 7 papers in Epidemiology. Recurrent topics in Bhupender Kumar's work include Cancer, Hypoxia, and Metabolism (8 papers), RNA modifications and cancer (6 papers) and Metabolism, Diabetes, and Cancer (4 papers). Bhupender Kumar is often cited by papers focused on Cancer, Hypoxia, and Metabolism (8 papers), RNA modifications and cancer (6 papers) and Metabolism, Diabetes, and Cancer (4 papers). Bhupender Kumar collaborates with scholars based in India, Kuwait and Finland. Bhupender Kumar's co-authors include R. Bamezai, Mohammad Askandar Iqbal, Siddharth Manvati, Farid Ahmad Siddiqui, Vibhor Gupta, Gopinath Prakasam, Taruna Kumari, Rajnish Kumar Singh, Shilpi Chattopadhyay and Kalaiarasan Ponnusamy and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Bhupender Kumar

27 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bhupender Kumar India 15 315 173 100 57 35 28 490
Chaoliang Liao China 12 326 1.0× 226 1.3× 74 0.7× 80 1.4× 51 1.5× 13 492
Rui Yan China 11 224 0.7× 104 0.6× 56 0.6× 38 0.7× 46 1.3× 36 446
Xingsi Liang China 11 404 1.3× 213 1.2× 70 0.7× 86 1.5× 39 1.1× 12 546
Jingjing Wu China 14 309 1.0× 112 0.6× 55 0.6× 55 1.0× 31 0.9× 27 535
Yangqiu Bai China 12 181 0.6× 96 0.6× 80 0.8× 58 1.0× 19 0.5× 26 418
Fugen Shangguan China 14 333 1.1× 126 0.7× 65 0.7× 62 1.1× 60 1.7× 21 510
Kaitlin D. Werle United States 9 386 1.2× 147 0.8× 158 1.6× 102 1.8× 30 0.9× 10 559
Laura Ruíz-Cañas Spain 10 237 0.8× 106 0.6× 147 1.5× 103 1.8× 25 0.7× 22 496
Rui Song China 13 275 0.9× 217 1.3× 35 0.3× 74 1.3× 53 1.5× 53 504
Yanghe Zhang China 9 215 0.7× 151 0.9× 45 0.5× 40 0.7× 43 1.2× 16 385

Countries citing papers authored by Bhupender Kumar

Since Specialization
Citations

This map shows the geographic impact of Bhupender Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bhupender Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bhupender Kumar more than expected).

Fields of papers citing papers by Bhupender Kumar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bhupender Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bhupender Kumar. The network helps show where Bhupender Kumar may publish in the future.

Co-authorship network of co-authors of Bhupender Kumar

This figure shows the co-authorship network connecting the top 25 collaborators of Bhupender Kumar. A scholar is included among the top collaborators of Bhupender Kumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bhupender Kumar. Bhupender Kumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kumar, Bhupender, et al.. (2023). Assessment of Type 2 Diabetes Risk in General Population using Bitter Taste Sensitivity Status to Phenylthiocarbamide - A Pilot Study. The Indian Journal of Nutrition and Dietetics. 201–213. 1 indexed citations
2.
Kumar, Bhupender, et al.. (2023). CDH1 overexpression sensitizes TRAIL resistant breast cancer cells towards rhTRAIL induced apoptosis. Molecular Biology Reports. 50(9). 7283–7294. 2 indexed citations
3.
Singh, Prithvi, Archana Sharma, Bhupender Kumar, et al.. (2023). Integrative multiomics and weighted network approach reveals the prognostic role of RPS7 in lung squamous cell carcinoma pathogenesis. Journal of Applied Genetics. 64(4). 737–748. 4 indexed citations
4.
Singh, Prithvi, Prakash Jha, Md. Zubbair Malik, et al.. (2023). Investigating the link between miR-34a-5p and TLR6 signaling in sepsis-induced ARDS. 3 Biotech. 13(8). 282–282. 4 indexed citations
5.
Smith, Kirk, et al.. (2023). Metabolic stratification of human breast tumors reveal subtypes of clinical and therapeutic relevance. iScience. 26(10). 108059–108059. 5 indexed citations
6.
Arora, Taruna, et al.. (2023). Visceral fat: A key mediator of NAFLD development and progression. SHILAP Revista de lepidopterología. 33. 200210–200210. 28 indexed citations
7.
Kumar, Bhupender, et al.. (2022). Deciphering the role of aberrant DNA methylation in NAFLD and NASH. Heliyon. 8(10). e11119–e11119. 25 indexed citations
8.
Kumar, Bhupender, et al.. (2021). Association of PARK-2 Non-synonyms Polymorphisms and Their In Silico Validation Among North Indian Colorectal Cancer Patients. Journal of Gastrointestinal Cancer. 53(3). 674–682. 1 indexed citations
9.
Iqbal, Mohammad Askandar, Asad Rehman, Farid Ahmad Siddiqui, et al.. (2021). Multiomics integrative analysis reveals antagonistic roles of CBX2 and CBX7 in metabolic reprogramming of breast cancer. Molecular Oncology. 15(5). 1450–1465. 29 indexed citations
10.
Kumar, Bhupender, et al.. (2018). Association of PARK2 promoter polymorphisms and methylation with colorectal cancer in North Indian population. Gene. 682. 25–32. 13 indexed citations
11.
Kumari, Taruna, et al.. (2018). Meta-analysis of mitochondrial T16189C polymorphism for cancer and Type 2 diabetes risk. Clinica Chimica Acta. 482. 136–143. 17 indexed citations
12.
Kumari, Taruna & Bhupender Kumar. (2018). High-mobility group box 1 protein (HMGB1) gene polymorphisms and cancer susceptibility: A comprehensive meta-analysis. Clinica Chimica Acta. 483. 170–182. 18 indexed citations
13.
Ponnusamy, Kalaiarasan, et al.. (2017). Genetic and epigenetic alterations affecting PARK-2 expression in cervical neoplasm among North Indian patients. Tumor Biology. 39(6). 3726131963–3726131963. 9 indexed citations
14.
Kumar, Bhupender, Savita Bansal, Sunil Saini, et al.. (2017). Association of mitochondrial copy number variation and T16189C polymorphism with colorectal cancer in North Indian population. Tumor Biology. 39(11). 3726135629–3726135629. 21 indexed citations
15.
Kumar, Bhupender, Mohammad Askandar Iqbal, Rajnish Kumar Singh, & R. Bamezai. (2015). Resveratrol inhibits TIGAR to promote ROS induced apoptosis and autophagy. Biochimie. 118. 26–35. 43 indexed citations
16.
17.
Manvati, Siddharth, et al.. (2014). MiR-101 Induces Senescence and Prevents Apoptosis in the Background of DNA Damage in MCF7 Cells. PLoS ONE. 9(10). e111177–e111177. 14 indexed citations
18.
Iqbal, Mohammad Askandar, Farid Ahmad Siddiqui, Vibhor Gupta, et al.. (2014). Missense Mutations in Pyruvate Kinase M2 Promote Cancer Metabolism, Oxidative Endurance, Anchorage Independence, and Tumor Growth in a Dominant Negative Manner. Journal of Biological Chemistry. 289(12). 8098–8105. 19 indexed citations
19.
Iqbal, Mohammad Askandar, Farid Ahmad Siddiqui, Vibhor Gupta, et al.. (2013). Insulin enhances metabolic capacities of cancer cells by dual regulation of glycolytic enzyme pyruvate kinase M2. Molecular Cancer. 12(1). 72–72. 87 indexed citations
20.
Chopra, Rupali, Shafat Ali, Amit Srivastava, et al.. (2013). Mapping of PARK2 and PACRG Overlapping Regulatory Region Reveals LD Structure and Functional Variants in Association with Leprosy in Unrelated Indian Population Groups. PLoS Genetics. 9(7). e1003578–e1003578. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026